Literature DB >> 26453563

Huaiqihuang Granules () reduce proteinuria by enhancing nephrin expression and regulating necrosis factor κB signaling pathway in adriamycin-induced nephropathy.

Hong Liu1,2, Wei Sun3, Liu-Bao Gu4, Yue Tu2, Bing-Yin Yu2, Hao Hu2.   

Abstract

OBJECTIVE: To investigate the effects of Huaiqihuang Granules (, HQH), a mixture of Chinese herbs including Trametes robiniophila Murr, Fructus Lycii and Polygonatum sibiricum, on adriamycininduced nephropathy (ADRN) in rats and its underlying mechanisms.
METHODS: Rats with ADRN were divided into four groups: the sham group, the model group (distilled water), the low-dose HQH-treated (2 g/kg) group, and the high-dose HQH-treated (4 g/kg) group. Body weight and 24-h urinary protein (Upro) were checked every week. After 5-week intervention, at the end of the study, the rats were sacrificed and blood samples were collected for examination of biochemical parameters, including glomerular morphological makers, podocyte shape, cellular apoptosis, expressions of nephrin, inflammatory and apoptosis markers.
RESULTS: HQH ameliorated the rat's general status, proteinuria, renal morphological appearance and glomerulosclerosis. The decreased expression of nephrin in ADRN rats was increased by HQH, as well as the impaired podocyte foot process fusion. Cytosolic levels of p65 and inhibitor of nuclear factor κBα (IκBα) were decreased in ADRN rats, and recovered by the treatment of HQH. Consistently, the induced expression of tumor necrosis factor α (TNF-α), phosphorylated nuclear factor κB p65 (p-NFκB p65) and IκBα in ADRN were markedly suppressed by HQH. In addition, induction of Bax, cleaved caspase-3 and cytochrome C in ADRN rats were suppressed by HQH, indicating the amelioration of apoptosis.
CONCLUSION: HQH could ameliorate renal impairments in ADRN rats by increasing nephrin expression, inhibiting NF-κB signaling pathway via the down-regulation of p-NF-κB p65 and p-IκBα, and suppression of glomerular and tubular apoptosis.

Entities:  

Keywords:  Chinese medicine; Huaiqihuang Granules; adriamycin-induced nephropathy; apoptosis; nephrin; nuclear transcription factor kappa B

Mesh:

Substances:

Year:  2015        PMID: 26453563     DOI: 10.1007/s11655-015-2293-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  29 in total

1.  Effects of 22-oxa-calcitriol on podocyte injury in adriamycin-induced nephrosis.

Authors:  Aida Lydia; Katsuhiko Asanuma; Kanae Nonaka; Miyuki Takagi; Kyung-Hwan Jeong; Fumiko Kodama; Rin Asao; Etsuko Asanuma; Wiguno Prodjosudjadi; Yasuhiko Tomino
Journal:  Am J Nephrol       Date:  2011-12-21       Impact factor: 3.754

Review 2.  The podocyte's response to injury: role in proteinuria and glomerulosclerosis.

Authors:  S J Shankland
Journal:  Kidney Int       Date:  2006-05-10       Impact factor: 10.612

3.  Transcriptional suppression of nephrin in podocytes by macrophages: roles of inflammatory cytokines and involvement of the PI3K/Akt pathway.

Authors:  Yosuke Takano; Kozue Yamauchi; Kunihiro Hayakawa; Nobuhiko Hiramatsu; Ayumi Kasai; Maro Okamura; Makiko Yokouchi; Akihiro Shitamura; Jian Yao; Masanori Kitamura
Journal:  FEBS Lett       Date:  2007-01-12       Impact factor: 4.124

4.  Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line.

Authors:  S Legrand-Poels; S Schoonbroodt; J Piette
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

5.  Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome.

Authors:  Kristin A D Sauter; Lisa J Wood; John Wong; Mihail Iordanov; Bruce E Magun
Journal:  Cancer Biol Ther       Date:  2011-06-15       Impact factor: 4.742

6.  Differential effects of chemotherapeutic agents on the Bcl-2/Bax apoptosis pathway in human breast cancer cell line MCF-7.

Authors:  L K Leung; T T Wang
Journal:  Breast Cancer Res Treat       Date:  1999-05       Impact factor: 4.872

7.  Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome.

Authors:  S Doublier; V Ruotsalainen; G Salvidio; E Lupia; L Biancone; P G Conaldi; P Reponen; K Tryggvason; G Camussi
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

Review 8.  Why is proteinuria an ominous biomarker of progressive kidney disease?

Authors:  Kambiz Zandi-Nejad; Allison A Eddy; Richard J Glassock; Barry M Brenner
Journal:  Kidney Int Suppl       Date:  2004-11       Impact factor: 10.545

Review 9.  Functions of the podocyte proteins nephrin and Neph3 and the transcriptional regulation of their genes.

Authors:  Mervi Ristola; Sanna Lehtonen
Journal:  Clin Sci (Lond)       Date:  2014-03       Impact factor: 6.124

Review 10.  NF-kappaB signalling in chronic kidney disease.

Authors:  Gopala Rangan; Yiping Wang; David Harris
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  7 in total

1.  Risk factors and clinical characteristics of tacrolimus-induced acute nephrotoxicity in children with nephrotic syndrome: a retrospective case-control study.

Authors:  Ping Gao; Xin-Lei Guan; Rui Huang; Xiao-Fang Shang-Guan; Jiang-Wei Luan; Mao-Chang Liu; Hua Xu; Xiao-Wen Wang
Journal:  Eur J Clin Pharmacol       Date:  2019-11-19       Impact factor: 2.953

2.  Huaiqihuang may protect from proteinuria by resisting MPC5 podocyte damage via targeting p-ERK/CHOP pathway.

Authors:  Tingxia Li; Jianhua Mao; Lei Huang; Haidong Fu; Shuohui Chen; Aimin Liu; Yuqin Liang
Journal:  Bosn J Basic Med Sci       Date:  2016-05-17       Impact factor: 3.363

Review 3.  Recent Advances in Traditional Chinese Medicine for Treatment of Podocyte Injury.

Authors:  Tianwen Yao; Wenxiang Su; Shisheng Han; Yan Lu; Yanqiu Xu; Min Chen; Yi Wang
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

Review 4.  Traditional Chinese Medicine in the Treatment of Chronic Kidney Diseases: Theories, Applications, and Mechanisms.

Authors:  Yunlai Wang; Ye Feng; Manman Li; Mo Yang; Gaoxiang Shi; Zihua Xuan; Dengke Yin; Fan Xu
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

Review 5.  Efficacy and safety of Huaiqihuang granule as adjuvant treatment for primary nephrotic syndrome in children: a meta-analysis and systematic review.

Authors:  Jiao Lin; Li-Min Huang; Jing-Jing Wang; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2021-06-01       Impact factor: 2.764

6.  Pretreatment of Huaiqihuang extractum protects against cisplatin-induced nephrotoxicity.

Authors:  Yujiao Guo; Meng Wang; Jingyi Mou; Zhi Zhao; Juan Yang; Fengming Zhu; Guangchang Pei; Han Zhu; Yuxi Wang; Gang Xu; Rui Zeng; Ying Yao
Journal:  Sci Rep       Date:  2018-05-09       Impact factor: 4.379

Review 7.  The Effect of Chinese Traditional Medicine Huaiqihuang (HQH) on the Protection of Nephropathy.

Authors:  Xueyan Zhang; Yiyu Cheng; Qian Zhou; Haojie Huang; Yinmiao Dong; Yang Yang; Mingyi Zhao; Qingnan He
Journal:  Oxid Med Cell Longev       Date:  2020-06-16       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.